在新生儿ICU中以药理动力学模型为指导的氧沙剂量:回顾性队列研究计划未来可行性试验
Haden Bunn1, Catherine Schentag2, Leonardo R Brandão3,4
1Pumas-AI, Inc, Dover, Delaware, USA.
Clinical and translational science
|October 1, 2024
概括
与标准护理相比,新生儿中素的药理动力学模型知情精确剂量 (MIPD) 导致初始剂量更高. 这种方法可以减少在这个脆弱人群中达到治疗性抗Xa水平的时间.
科学领域:
- 新生儿药理学 新生儿药理学
- 药理动力学和药理动力学
- 药物剂量优化药物剂量优化
背景情况:
- 在新生儿中使用标准的埃诺沙巴林剂量往往无法及时达到治疗性抗Xa水平.
- 这需要频繁的实验室监测和剂量调整,增加医疗负担.
研究的目的:
- 为了比较标准护理 (SOC) 毫克/千克剂量与新生儿内沙的药理动力学 (PK) 模型知情精度剂量 (MIPD).
- 评估MIPD对实现目标抗Xa水平和达到治疗水平的时间的影响.
主要方法:
- 对168名住院新生儿 (月经后不到44周) 进行了回顾性分析,这些新生儿接受了Enoxaparin治疗.
- 使用Pumas-AI Lyv剂量工具,将SOC初始素剂量与MIPD推剂量进行比较.
- 作为次要结果,分析达到治疗性抗Xa水平的时间.
主要成果:
- 在32%的病例中,MIPD建议初始的氧沙巴林剂量比SOC高20%-60%,在11%的病例中,超过60%以上.
- 接受SOC剂量明显低于MIPD建议的新生儿在达到治疗性抗Xa水平的延迟时间最长.
- 与SOC相比,以PK模型为基础的剂量产生了较高的初始埃诺沙巴林剂量.
结论:
- 在新生儿中以PK模型为基础精确剂量注射埃诺沙巴林,导致初始剂量高于标准护理.
- 这一策略有可能减少在新生儿中达到治疗性抗Xa水平的时间.
- 这些发现正在为新生儿重症监护机构中MIPD的前性试验提供剂量限制信息.
相关概念视频
One-Compartment Open Model for IV Bolus Administration: General Considerations
167
The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
167
Analysis of Population Pharmacokinetic Data
237
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
237
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
51
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
51
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation
411
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
On...
411
Nonlinear Pharmacokinetics: Overview
302
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...
302
One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution
222
The one-compartment open model is a simplified approach used in pharmacokinetics to understand the distribution and elimination of a drug administered through an intravenous bolus. This model assumes rapid drug dispersal throughout the body and elimination using a first-order process. Key pharmacokinetic parameters, such as the elimination rate constant (k), half-life (t1/2), and the apparent volume of distribution (Vd), can be estimated from this model. The elimination rate is calculated...
222


